Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators.

Denschlag D, Heitz F, Pfisterer J, Tutschkow D, Reuss A, Meier W, Harter P, Wimberger P, Mirza MR, Ray-Coquard I, Scambia G, Kim JW, Colombo N, Oaknin A, Sehouli J, Lindemann K, Lebreton C, Eichbaum M, Spiegelberg S, Woopen H, du Bois A

Open source

DOI: 10.1136/ijgc-2024-005663
Published: 2024 Dec 2
Container: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/ijgc-2024-005663,
  title = {Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators.},
  author = {Denschlag D and Heitz F and Pfisterer J and Tutschkow D and Reuss A and Meier W and Harter P and Wimberger P and Mirza MR and Ray-Coquard I and Scambia G and Kim JW and Colombo N and Oaknin A and Sehouli J and Lindemann K and Lebreton C and Eichbaum M and Spiegelberg S and Woopen H and du Bois A},
  year = {2024},
  journal = {International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
  doi = {10.1136/ijgc-2024-005663},
  url = {https://doi.org/10.1136/ijgc-2024-005663}
}

RIS

TY  - JOUR
TI  - Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators.
AU  - Denschlag D
AU  - Heitz F
AU  - Pfisterer J
AU  - Tutschkow D
AU  - Reuss A
AU  - Meier W
AU  - Harter P
AU  - Wimberger P
AU  - Mirza MR
AU  - Ray-Coquard I
AU  - Scambia G
AU  - Kim JW
AU  - Colombo N
AU  - Oaknin A
AU  - Sehouli J
AU  - Lindemann K
AU  - Lebreton C
AU  - Eichbaum M
AU  - Spiegelberg S
AU  - Woopen H
AU  - du Bois A
PY  - 2024
JO  - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
DO  - 10.1136/ijgc-2024-005663
UR  - https://doi.org/10.1136/ijgc-2024-005663
ER  -

APA

D, D., F, H., J, P., D, T., A, R., W, M., P, H., P, W., MR, M., I, R., G, S., JW, K., N, C., A, O., J, S., K, L., C, L., M, E., S, S., H, W., & A, D. B. (2024). Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. https://doi.org/10.1136/ijgc-2024-005663

Source records

pubmed · retrieved 2026-09-26T18:21:50.314Z